Ironwood Pharmaceuticals Profile

20.16
USD 0.10  0.50%
61%
45%

Exercise or conversion by Peter Hecht of 26595 shares of Ironwood Pharmaceuticals subject to Rule 16b-3

Ironwood Pharmaceuticals insider trading alert for exercise of employee stock option (right to buy) by Peter Hecht, Chief Executive Officer, on July 15, 2018. This event was filed by Ironwood Pharmaceuticals with SEC on 2017-12-08. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Ironwood Pharmaceuticals Summary

Ironwood Pharmaceuticals (IRWD) is traded on NASDAQ in USA. It is located in 301 Binney Street and employs 730 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 3.2 B. Ironwood Pharmaceuticals conducts business under Healthcare sector and is part of Pharmaceutical Products industry. This company has 137.94 M outstanding shares of which 18.97 M shares are currently shorted by private and institutional investors with about 14.45 trading days to cover. Ironwood Pharmace currently holds about 194.45 M in cash with (102.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.28.
Check Ironwood Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 20.16HorizonTargetOdds Above 20.16
73.63%30 days 20.16 26.14%
Based on normal probability distribution, the odds of Ironwood Pharmaceuticals to move above current price in 30 days from now is about 26.14% (This Ironwood Pharmaceuticals probability density function shows the probability of Ironwood Pharmaceuticals Stock to fall within a particular range of prices over 30 days) .

Top Holders

Ironwood Pharmaceuticals Risk Profiles

Key Fundamentals

Ironwood Pharmaceuticals Against Markets

Current Ratings

Ironwood Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
11 
Chance of
Financial Distress (0 to 100%)
26 
Equity ratings for Ironwood Pharmaceuticals are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Ironwood Pharmaceuticals, Inc., a commercial biotechnology company, engages in the research, development, and commercialization of human therapeutic products. Ironwood Pharmaceuticals, Inc. was founded in 1998 and is headquartered in Cambridge, Massachusetts. Ironwood Pharmaceuticals operates under Drug Manufacturers - Specialty Generic classification in USA and traded on NASDAQ. It employs 730 people. more
NameIronwood Pharmaceuticals
Co-Founder, CEO and DirectorPeter HechtView All
Thematic Classification
Currently Active Investing Idea
  Obamacare Repeal
View All
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock View All
Business Address301 Binney Street
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.ironwoodpharma.com
Phone617 621 7722
CurrencyUSD - US Dollar

Ironwood Pharmaceuticals Corporate Directors

Terrance McGuire Independent Director, MBA
Meredith Kaya Director - Investor Relations
Julie McHugh Independent Director
Please also check Risk vs Return Analysis. Please also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">